University of Arizona College of Medicine
Amyloid Imaging for Alzheimer's Disease is one of a continuing series of practical, evidence based, Provider Fact Sheets which summarize key geriatric topics and provide clinically useful assessments and interventions. Initially developed for remote, rural clinical sites, they are useful for students and health care professionals from many fields and across a very broad range of health care settings.
- Describe what is seen on a positive vs a negative florbetapir amyloid scan in Alzheimer’s disease
- List three situation in which a florbetapir amyloid scan may aid in determining if a patient has Alzheimer’s disease.
- State the most common dementia (other than Alzheimer’s disease) that may have a positive florbetapir amyloid scan
Subscribers to POGOe are free to reprint Elder Care on their own stationery or in other publications without obtaining specific permission, so long as:
- Content is not changed,
- No one is charged a fee to use or read the publication,
- Authors and their affiliated institutions are noted without change, and
- The reprint includes the following statement: “Reprinted courtesy of the Arizona Reynolds Program of Applied Geriatrics and the Arizona Geriatric Education Center."